Cargando…

Reply: A morpho-molecular prognostic model for hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Srivastava, S, Salto-Tellez, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593532/ https://www.ncbi.nlm.nih.gov/pubmed/23422790 http://dx.doi.org/10.1038/bjc.2012.515

Ejemplares similares

A morpho-molecular prognostic model for hepatocellular carcinoma
por: Srivastava, S, et al.
Publicado: (2012)

A comment on ‘A morpho-molecular prognostic model for hepatocellular carcinoma'
por: Halil Sahin, I, et al.
Publicado: (2013)

Prognostic factors in gastric carcinoma - reply
por: Setälä, Leena, et al.
Publicado: (1997)

Time for change: a new training programme for morpho-molecular pathologists?
por: Moore, David A, et al.
Publicado: (2018)

In Reply: Neoadjuvant TKI Study in Early- and Intermediate Stage Hepatocellular Carcinoma
por: Osanto, Susanne, et al.
Publicado: (2022)

Author's reply
por: Srivastava, A., et al.
Publicado: (2007)

Author’s reply
por: Srivastava, M. V. Padma
Publicado: (2010)

The complexity of immune cell landscape in hepatocellular carcinomas with different risks—reply letter
por: Tang, Xiaofeng, et al.
Publicado: (2020)

Reply to: “Malignant transformation of hepatocellular adenoma”
por: Chopinet, Sophie, et al.
Publicado: (2022)

Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma – a reply
por: Guerry, M, et al.
Publicado: (2000)

Reply to: Comment on ‘Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area'
por: Sideras, Kostandinos, et al.
Publicado: (2016)

Reply to: “Reconsidering low HDL-cholesterol levels as a predictive factor for the development of hepatocellular carcinoma”
por: Crudele, Lucilla, et al.
Publicado: (2023)

Reply to ‘Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’ ’
por: Waked, Iman, et al.
Publicado: (2017)

Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.
por: Choi, Won-Mook, et al.
Publicado: (2022)

ARDS in SARS: cytokine mediators and treatment implications
por: Salto-Tellez, Manuel, et al.
Publicado: (2005)

Reply to: Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Johnson, Philip, et al.
Publicado: (2016)

Reply to ‘Comment on ‘Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis”
por: Almangush, Alhadi, et al.
Publicado: (2018)

Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis
por: Miao, Yan-Dong, et al.
Publicado: (2022)

Reply to: Prognostic implications of vitamin D in patients with COVID-19
por: Hastie, Claire E., et al.
Publicado: (2020)

Reply to: “Ductular reaction is a prognostic factor in primary biliary cholangitis”
por: Carpino, Guido, et al.
Publicado: (2023)

Author Reply – SOFA-based Prognostication in PICU: A Cardiovascular Critique!
por: Lois, Amoolya, et al.
Publicado: (2023)

Prognostic value of circulating chromogranin A levels in acute coronary syndrome: reply
por: Røsjø, Helge, et al.
Publicado: (2010)

Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular carcinoma”
por: Yang, Yun, et al.
Publicado: (2023)

Genetic landscape of prognostic value in pancreas ductal adenocarcinoma microenvironment—reply
por: Pu, Ning, et al.
Publicado: (2020)

Reply
por: Lokken, Erica M., et al.
Publicado: (2020)

Reply()
por: Barrios-López, J.M., et al.
Publicado: (2021)

Reply
por: Cavuoto, Kara M.
Publicado: (2021)

Reply
por: Yonker, Lael M., et al.
Publicado: (2021)

Reply
por: Yonker, Lael M., et al.
Publicado: (2021)

In Reply
por: Goldberg, Richard M., et al.
Publicado: (2017)

Reply
por: Pinto-Sanchez, M. Ines, et al.
Publicado: (2021)

Reply
por: Derespina, Kim R., et al.
Publicado: (2021)

Reply
por: Forrer, F., et al.
Publicado: (2007)

Reply: Imaging-Based Obesity Assessment for Risk Factor Stratification and Prognostication in Malignancy
por: Liu, Elizabeth E., et al.
Publicado: (2022)

Reply
por: Villaverde, Serena, et al.
Publicado: (2021)

Reply: Inflammatory breast carcinoma as a model of accelerated self-metastatic expansion by intra-vascular growth
por: Enderling, H, et al.
Publicado: (2009)

Reply
por: Algarroba, Gabriela N., et al.
Publicado: (2020)

Reply: molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation
por: Yoshikawa, R, et al.
Publicado: (2008)

Reply
por: Yonker, Lael M., et al.
Publicado: (2021)

Reply
por: Yonker, Lael M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oo26kqbh0hhoft2eid2e7p2l8c